GB0504209D0 - New use of PDE7 inhibitors - Google Patents

New use of PDE7 inhibitors

Info

Publication number
GB0504209D0
GB0504209D0 GB0504209A GB0504209A GB0504209D0 GB 0504209 D0 GB0504209 D0 GB 0504209D0 GB 0504209 A GB0504209 A GB 0504209A GB 0504209 A GB0504209 A GB 0504209A GB 0504209 D0 GB0504209 D0 GB 0504209D0
Authority
GB
United Kingdom
Prior art keywords
new use
pde7 inhibitors
pde7
inhibitors
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0504209A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0504209A priority Critical patent/GB0504209D0/en
Publication of GB0504209D0 publication Critical patent/GB0504209D0/en
Priority to AU2006219643A priority patent/AU2006219643A1/en
Priority to CA002599662A priority patent/CA2599662A1/en
Priority to RU2007132865/15A priority patent/RU2007132865A/en
Priority to BRPI0607402-2A priority patent/BRPI0607402A2/en
Priority to CNA2006800090675A priority patent/CN101146539A/en
Priority to PCT/IB2006/000369 priority patent/WO2006092691A1/en
Priority to US11/817,528 priority patent/US20090111837A1/en
Priority to MX2007010721A priority patent/MX2007010721A/en
Priority to PCT/IB2006/000385 priority patent/WO2006092692A1/en
Priority to EP06710434A priority patent/EP1855686A1/en
Priority to KR1020077020010A priority patent/KR20070107099A/en
Priority to ARP060100717 priority patent/AR053687A1/en
Priority to TW095106683A priority patent/TW200642687A/en
Priority to TW095106687A priority patent/TW200642688A/en
Priority to JP2006053415A priority patent/JP4512052B2/en
Priority to ARP060100746 priority patent/AR053148A1/en
Priority to JP2006052759A priority patent/JP2006241158A/en
Priority to IL185485A priority patent/IL185485A0/en
Priority to ZA200707147A priority patent/ZA200707147B/en
Ceased legal-status Critical Current

Links

GB0504209A 2005-03-01 2005-03-01 New use of PDE7 inhibitors Ceased GB0504209D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB0504209A GB0504209D0 (en) 2005-03-01 2005-03-01 New use of PDE7 inhibitors
KR1020077020010A KR20070107099A (en) 2005-03-01 2006-02-16 Use of pde7 inhibitors for the treatment of neuropathic pain
MX2007010721A MX2007010721A (en) 2005-03-01 2006-02-16 Use of pde7 inhibitors for the treatment of neuropathic pain.
EP06710434A EP1855686A1 (en) 2005-03-01 2006-02-16 Use of pde7 inhibitors for the treatment of neuropathic pain
RU2007132865/15A RU2007132865A (en) 2005-03-01 2006-02-16 APPLICATION OF PDE7 INHIBITORS FOR TREATMENT OF NEUROPATHIC PAIN
BRPI0607402-2A BRPI0607402A2 (en) 2005-03-01 2006-02-16 use of pde7 inhibitors to treat neuropathic pain
CNA2006800090675A CN101146539A (en) 2005-03-01 2006-02-16 Use of pde7 inhibitors for the treatment of neuropathic pain
PCT/IB2006/000369 WO2006092691A1 (en) 2005-03-01 2006-02-16 Use of pde7 inhibitors for the treatment of neuropathic pain
US11/817,528 US20090111837A1 (en) 2005-03-01 2006-02-16 Use of pde7 inhibitors for the treatment of neuropathic pain
AU2006219643A AU2006219643A1 (en) 2005-03-01 2006-02-16 Use of PDE7 inhibitors for the treatment of neuropathic pain
PCT/IB2006/000385 WO2006092692A1 (en) 2005-03-01 2006-02-16 Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
CA002599662A CA2599662A1 (en) 2005-03-01 2006-02-16 Use of pde7 inhibitors for the treatment of neuropathic pain
TW095106687A TW200642688A (en) 2005-03-01 2006-02-27 New use of PDE7 inhibitors
ARP060100717 AR053687A1 (en) 2005-03-01 2006-02-27 NEW USE OF PHOSPHODIESTERASE 7 (PDE7) INHIBITORS
TW095106683A TW200642687A (en) 2005-03-01 2006-02-27 Combinations comprising α-2-δ ligands
JP2006053415A JP4512052B2 (en) 2005-03-01 2006-02-28 New uses of PDE7 inhibitors
ARP060100746 AR053148A1 (en) 2005-03-01 2006-02-28 COMBINATIONS UNDERSTANDING ALFA-2- DELTA LIGANDS
JP2006052759A JP2006241158A (en) 2005-03-01 2006-02-28 CONCOMITANT MEDICINE CONTAINING alpha-2-delta-LIGAND
IL185485A IL185485A0 (en) 2005-03-01 2007-08-23 Use of pde7 inhibitors for the treatment of neuropathic pain
ZA200707147A ZA200707147B (en) 2005-03-01 2007-08-23 Use of PDE7 inhibitors for the treatment of neuropathic pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0504209A GB0504209D0 (en) 2005-03-01 2005-03-01 New use of PDE7 inhibitors

Publications (1)

Publication Number Publication Date
GB0504209D0 true GB0504209D0 (en) 2005-04-06

Family

ID=34430434

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0504209A Ceased GB0504209D0 (en) 2005-03-01 2005-03-01 New use of PDE7 inhibitors

Country Status (6)

Country Link
JP (1) JP4512052B2 (en)
CN (1) CN101146539A (en)
AR (1) AR053687A1 (en)
GB (1) GB0504209D0 (en)
TW (1) TW200642688A (en)
ZA (1) ZA200707147B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102731512B (en) * 2011-04-12 2015-04-22 天津药物研究院 Preparation method of lurasidone intermediate and lurasidone
CN104211638A (en) * 2014-08-13 2014-12-17 李增 Fatty amino substituted graveoline derivative, its preparation and its application as anti-Alzheimer's disease medicine
TWI826928B (en) * 2022-02-16 2023-12-21 翁豐富 Synthesis of tricyclic and tetracyclic genipin derivatives as anti-inflammation substance and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076953A1 (en) * 2001-03-21 2002-10-03 Warner-Lambert Company Llc New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
EP1400244A1 (en) * 2002-09-17 2004-03-24 Warner-Lambert Company LLC New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors

Also Published As

Publication number Publication date
JP2006241159A (en) 2006-09-14
CN101146539A (en) 2008-03-19
AR053687A1 (en) 2007-05-16
TW200642688A (en) 2006-12-16
JP4512052B2 (en) 2010-07-28
ZA200707147B (en) 2008-11-26

Similar Documents

Publication Publication Date Title
ZA200802585B (en) Pyridopyrimidinone inhibitors of Pl3Kα
IL190292A0 (en) PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
ZA200706345B (en) Amino-pyridines as inhibitors of ß-secretase
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
IL179398A0 (en) Dpp-ib inhibitors
EP2023718A4 (en) Creatine-ligand compounds and methods of use thereof
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
ZA200707650B (en) Azolylacylguanidines as ß-secretase inhibitors
HK1100930A1 (en) Inhibitors of iap iap
HK1105592A1 (en) Aryl-pyridine derivatives as 1-beta-hsd1 inhibitors
ZA200702394B (en) Indozolone derivatives as 11b-HSD1 inhibitors
EP1756092A4 (en) Novel inhibitors of rho-kinases
IL194028A0 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
EP2084139A4 (en) Oxazolidinium compounds and use as hydrate inhibitors
HK1137756A1 (en) Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors hif--4-
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
ZA200903058B (en) Heterocyclic derived metalloprotease inhibitors
HK1161122A1 (en) Use of 24-norudca 24-norudca
GB0421355D0 (en) Inhibitors
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
EP1931370A4 (en) Use of des-aspartate-angiotensin i
GB0504209D0 (en) New use of PDE7 inhibitors
GB0421356D0 (en) Inhibitors
ZA200901009B (en) Aza-benzothiophenyl compounds and methods of use
GB0516967D0 (en) Inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)